These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 23603006

  • 1. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, Ghaffari SM, Abdirad A.
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [Abstract] [Full Text] [Related]

  • 2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 3. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T, Zhu J, Zhu L, Cheng M.
    Nutrients; 2017 Feb 27; 9(3):. PubMed ID: 28264426
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, Yu C, Jing F, Chen W, Gao L, Zhao J.
    PLoS One; 2014 Feb 27; 9(6):e99245. PubMed ID: 24926685
    [Abstract] [Full Text] [Related]

  • 5. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
    Yin J, Luo Y, Deng H, Qin S, Tang W, Zeng L, Zhou B.
    J Ethnopharmacol; 2014 May 28; 154(1):229-39. PubMed ID: 24735863
    [Abstract] [Full Text] [Related]

  • 6. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B.
    Cell Physiol Biochem; 2016 May 28; 40(3-4):453-464. PubMed ID: 27889747
    [Abstract] [Full Text] [Related]

  • 7. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E, Ebrahimi-Kalan A, Alipour MR.
    Biomed Pharmacother; 2019 Jan 28; 109():1306-1312. PubMed ID: 30551380
    [Abstract] [Full Text] [Related]

  • 8. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S, Kim J, Lee H, Lee H, Lim J, Yang H, Shin SS, Yoon M.
    J Ethnopharmacol; 2017 Jan 04; 195():204-213. PubMed ID: 27845265
    [Abstract] [Full Text] [Related]

  • 9. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
    Liu Y, Xu W, Zhai T, You J, Chen Y.
    Acta Pharm Sin B; 2019 Jul 04; 9(4):745-757. PubMed ID: 31384535
    [Abstract] [Full Text] [Related]

  • 10. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, Zhang J, Wang T, Xin W, Yu C, Guan Q, Zhou X, Gao L, Xu C, Zhao J.
    J Hepatol; 2014 Dec 04; 61(6):1358-64. PubMed ID: 25016220
    [Abstract] [Full Text] [Related]

  • 11. Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype.
    Rojas Á, Gallego P, Gil-Gómez A, Muñoz-Hernández R, Rojas L, Maldonado R, Gallego R, García-Valdecasas M, Del Campo JA, Bautista JD, Romero-Gómez M.
    Ann Hepatol; 2018 Mar 01; 17(2):242-249. PubMed ID: 29469041
    [Abstract] [Full Text] [Related]

  • 12. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y, Jin Y, Wen J, Li G, Huai X, Duan Y, Ni F, Fu J, Li M, Li L, Yan M, Cao L, Xiao W, Yang H, Wang ZZ.
    Biomed Pharmacother; 2024 Jul 01; 176():116908. PubMed ID: 38850668
    [Abstract] [Full Text] [Related]

  • 13. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.
    Hu XQ, Wang YM, Wang JF, Xue Y, Li ZJ, Nagao K, Yanagita T, Xue CH.
    Lipids Health Dis; 2010 Mar 09; 9():25. PubMed ID: 20211032
    [Abstract] [Full Text] [Related]

  • 14. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS, Park CM, Kim HA, Kim HJ, Park JW, Park JC, Rhyu DY.
    J Ethnopharmacol; 2024 Feb 10; 320():117395. PubMed ID: 37952731
    [Abstract] [Full Text] [Related]

  • 15. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW, Yin GL, Song CY, Meng DC, Yu WF, Zhang X, Feng YN, Liang PP, Zhang FX.
    Zhongguo Zhong Yao Za Zhi; 2023 Oct 10; 48(19):5304-5314. PubMed ID: 38114120
    [Abstract] [Full Text] [Related]

  • 16. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
    Chang JJ, Hsu MJ, Huang HP, Chung DJ, Chang YC, Wang CJ.
    J Agric Food Chem; 2013 Jun 26; 61(25):6069-76. PubMed ID: 23731091
    [Abstract] [Full Text] [Related]

  • 17. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610
    [Abstract] [Full Text] [Related]

  • 18. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model.
    Kim B, Woo MJ, Park CS, Lee SH, Kim JS, Kim B, An S, Kim SH.
    Phytother Res; 2017 Jan 15; 31(1):132-139. PubMed ID: 27762456
    [Abstract] [Full Text] [Related]

  • 19. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells.
    Chen JW, Kong ZL, Tsai ML, Lo CY, Ho CT, Lai CS.
    J Food Drug Anal; 2018 Jul 15; 26(3):1075-1085. PubMed ID: 29976400
    [Abstract] [Full Text] [Related]

  • 20. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells.
    Liu Y, Yu Q, Chen Y.
    Biomed Pharmacother; 2018 Dec 15; 108():716-723. PubMed ID: 30248539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.